Befotrik S 250mg/125mg Injection
Marketer
Blubell Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Befotrik S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be overseen by a physician. Complete the prescribed dosage; premature cessation can compromise efficacy. Missed doses should be avoided. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (rash, itching, edema, respiratory distress) require emergency care. Inform your doctor of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, a balanced diet, and ample hydration are crucial for optimal recovery. Your physician may order tests to monitor the medication's impact.
Uses of Befotrik S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Befotrik S 250mg/125mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Befotrik S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Befotrik S 250mg/125mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Befotrik S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Befotrik S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements this action by countering bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Befotrik S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Befotrik S (250mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Befotrik S 250mg/125mg Injection necessitates careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of their treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Befotrik S 250mg/125mg Injection might reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Befotrik S 250mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Befotrik S 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Befotrik S 250mg/125mg Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Befotrik S 250mg/125mg Injection :
Should you forget a scheduled dose of Befotrik S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Befotrik S 250mg/125mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Drugs combating infection |
3,018 People bought this recently